SCHEMBL29370435

SCHEMBL29370435

CCOC(=O)CC(NC1[C@H]2CN(CCCc3ccc4c(n3)N(C(=O)O)CCC4)C[C@@H]12)c1ccc(Cl)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 13/20 0.37
ITGAV P06756 13/20 0.37
ITGB6 P18564 12/20 0.37
ITGB5 P18084 5/20 0.37
ITGB8 P26012 5/20 0.37
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
ITGB1 P05556 1/20 0.33
ITGA5 P08648 1/20 0.33
ITGA2B P08514 1/20 0.33
TP53 P04637 1/20 0.32
THRB P10828 1/20 0.32
FGFR4 P22455 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
OPRM1 P35372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29369724 0.94 LMNA (0.40) ITGB3ITGAVITGB6ITGB5ITGB8
SCHEMBL29390969 0.91 ITGAV (0.34) ITGB3ITGAVITGB6ITGB5ITGB8
SCHEMBL29393359 0.85 LMNA (0.37) ITGB3ITGAVITGB6ITGB5ITGB8
SCHEMBL28694811 0.84 ITGB3 (0.36) ITGB3ITGAVITGB6ITGB5ITGB8
SCHEMBL29370042 0.84 ITGB3 (0.36) ITGB3ITGAVITGB6ITGB5ITGB8
SCHEMBL29370504 0.82 LMNA (0.39) ITGB3ITGAVITGB6ITGB5ITGB8
SCHEMBL20141284 0.82 ITGAV (0.45) ITGB3ITGAVITGB6ITGB5ITGB8
SCHEMBL29369651 0.74 ITGB3 (0.66) ITGB3ITGAVITGB6ITGB5ITGB8
SCHEMBL29369797 0.74 HRH3 (0.35) ITGB3ITGAVITGB6ITGB5ITGB1
SCHEMBL29369631 0.74 ITGB3 (0.43) ITGB3ITGAVITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022022364-A1 PYRROLIDINE INTEGRIN MODULATOR AND USE THEREOF 清药同创(北京)药物研发中心有限公司 2022-02-03 WO disclosed